Literature DB >> 28190076

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle.

Hironori Nishitsuji1, Hiromi Yamamoto2, Ritsuko Shiina2, Keisuke Harada3, Saneyuki Ujino2, Kunitada Shimotohno2.   

Abstract

Currently, it is possible to construct recombinant forms of various viruses, such as human immunodeficiency virus 1 (HIV-1) and hepatitis C virus (HCV), that carry foreign genes such as a reporter or marker protein in their genomes. These recombinant viruses usually faithfully mimic the life cycle of the original virus in infected cells and exhibit the same host range dependence. The development of a recombinant virus enables the efficient screening of inhibitors and the identification of specific host factors. However, to date the construction of recombinant hepatitis B virus (HBV) has been difficult because of various experimental limitations. The main limitation is the compact genome size of HBV, and a fairly strict genome size that does not exceed 1.3 genome sizes, that must be packaged into virions. Thus, the size of a foreign gene to be inserted should be smaller than 0.4 kb if no deletion of the genome DNA is to be performed. Therefore, to overcome this size limitation, the deletion of some HBV DNA is required. Here, we report the construction of recombinant HBV encoding a reporter gene to monitor the early stage of the HBV replication cycle by replacing part of the HBV core-coding region with the reporter gene by deleting part of the HBV pol coding region. Detection of recombinant HBV infection, monitored by the reporter activity, was highly sensitive and less expensive than detection using the currently available conventional methods to evaluate HBV infection. This system will be useful for a number of applications including high-throughput screening for the identification of anti-HBV inhibitors, host factors and virus-susceptible cells.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28190076      PMCID: PMC5407679          DOI: 10.3791/54849

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  21 in total

1.  Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as wel as for reverse transcription.

Authors:  R C Hirsch; J E Lavine; L J Chang; H E Varmus; D Ganem
Journal:  Nature       Date:  1990-04-05       Impact factor: 49.962

2.  Development of replicative and nonreplicative hepatitis B virus vectors.

Authors:  S Chaisomchit; D L Tyrrell; L J Chang
Journal:  Gene Ther       Date:  1997-12       Impact factor: 5.250

Review 3.  Hepatocellular carcinoma in cirrhosis: incidence and risk factors.

Authors:  Giovanna Fattovich; Tommaso Stroffolini; Irene Zagni; Francesco Donato
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

4.  An in vitro system for infection with hepatitis B virus that uses primary human fetal hepatocytes.

Authors:  T Ochiya; T Tsurimoto; K Ueda; K Okubo; M Shiozawa; K Matsubara
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

5.  Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens.

Authors:  Masaya Sugiyama; Yasuhito Tanaka; Takanobu Kato; Etsuro Orito; Kiyoaki Ito; Subrat K Acharya; Robert G Gish; Anna Kramvis; Takashi Shimada; Namiki Izumi; Masahiko Kaito; Yuzo Miyakawa; Masashi Mizokami
Journal:  Hepatology       Date:  2006-10       Impact factor: 17.425

Review 6.  Regulatory elements of hepatitis B virus transcription.

Authors:  Naazneen Moolla; Michael Kew; Patrick Arbuthnot
Journal:  J Viral Hepat       Date:  2002-09       Impact factor: 3.728

7.  Novel recombinant hepatitis B virus vectors efficiently deliver protein and RNA encoding genes into primary hepatocytes.

Authors:  Ran Hong; Weiya Bai; Jianwei Zhai; Wei Liu; Xinyan Li; Jiming Zhang; Xiaoxian Cui; Xue Zhao; Xiaoli Ye; Qiang Deng; Pierre Tiollais; Yumei Wen; Jing Liu; Youhua Xie
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

8.  In vitro experimental infection of primary human hepatocytes with hepatitis B virus.

Authors:  P R Galle; J Hagelstein; B Kommerell; M Volkmann; P Schranz; H Zentgraf
Journal:  Gastroenterology       Date:  1994-03       Impact factor: 22.682

9.  Replication-competent infectious hepatitis B virus vectors carrying substantially sized transgenes by redesigned viral polymerase translation.

Authors:  Zihua Wang; Li Wu; Xin Cheng; Shizhu Liu; Baosheng Li; Haijun Li; Fubiao Kang; Junping Wang; Huan Xia; Caiyan Ping; Michael Nassal; Dianxing Sun
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

10.  Hepatitis B virus transcription in the infected liver.

Authors:  R Cattaneo; H Will; H Schaller
Journal:  EMBO J       Date:  1984-09       Impact factor: 11.598

View more
  1 in total

1.  Multiple antiviral activities of the antimalarial and anti-hepatitis C drug candidates N-89 and N-251.

Authors:  Youki Ueda; Weilin Gu; Hiromichi Dansako; Hye-Sook Kim; Sayaka Yoshizaki; Nobuaki Okumura; Tomohiro Ishikawa; Hironori Nishitsuji; Fumihiro Kato; Takayuki Hishiki; Shinya Satoh; Koji Ishii; Michiaki Masuda; Kunitada Shimotohno; Masanori Ikeda; Nobuyuki Kato
Journal:  Biochem Biophys Rep       Date:  2018-06-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.